Notes to Accounts of Medinova Diagnostic Services Ltd.

Mar 31, 2025

M. Provision, contingent liabilities and contingent assets

A provision is recognised if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably, and it
is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future
cash flows (representing the best estimate of the expenditure required to settle the present obligation at the balance sheet date) at a pre-tax rate that
reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognised under
finance costs. Expected future operating losses are not provided for.

Contingencies:

Provision in respect of loss contingencies relating to claims, litigations, assessments, fines and penalties are recognised when it is probable that a
liability has been incurred and the amount can be estimated reliably.

M. Provision, contingent liabilities and contingent assets (Continued)

Contingent liabilities and contingent assets:

A- contingent liability exists when there is a possible but not probable obligation, or a present obligation that may, but probably will not, require an
outflow of resources, or a present obligation whose amount cannot be estimated reliably. Contingent liabilities do not warrant provisions, but are
disclosed unless the possibility of outflow of resources is remote.

Contingent assets has to be recognised in the financial statements in the period in which if it is virtually certain that an inflow of economic benefits will
arise. Contingent assets are assessed continually and no such benefits were found for the current financial year.

N. Earnings per share

Basic Earnings Per Share (‘EPS’) is computed by dividing the net profit attributable to the equity shareholders by the weighted average number of
equity shares outstanding during the year. Diluted earnings per share is computed by dividing the net profit by the weighted average number of equity
shares considered for deriving basic earnings per share and also the weighted average number of equity shares that could have been issued upon
conversion of all dilutive potential equity shares. Dilutive potential equity shares are deemed converted as of the beginning of the year, unless issued at
a later date. In computing diluted earnings per share, only potential equity shares that are dilutive and that either reduces earnings per share or increases
loss per share are included. The number of shares and potentially dilutive equity shares are adjusted retrospectively for all periods presented for the
share splits.

O. Statement of Cash Flow

Cash flows are reported using the indirect method, whereby net profit/ (loss) before tax is adjusted for the effects of transactions of a non-cash nature
and any deferrals or accruals of past or future cash receipts or payments and item of income or expenses associated with investing or financing cash
flows. The cash flows from regular revenue generating (operating activities), investing and financing activities of the Company are segregated.

P. Cash and cash equivalents

For the puipose of presentation in the statement of casli flows, cash and cash equivalents includes cash on hand, deposits held at call with financial
institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of
cash and which are subject to an insignificant risk of changes in value.

Q. Investments in subsidiaries

Investments representing equity interest in subsidiaries carried at cost less any provision for impairment. Investments are reviewed for impairment if
events or changes in circumstances indicate that the carrying amount may not be recoverable.

R. Events after reporting date

Where events occurring after the balance sheet date provide evidence of conditions that existed at the end of the reporting period, the impact of such
events is adjusted within the financial statements. Otherwise, events after the balance sheet date of material size or nature are only disclosed.

S. Recent accounting pronouncements

Ministry of Corporate Affairs (“MCA”) notifies new standards or amendments to the existing standards under Companies (Indian Accounting
Standards) Rules as issued from time to time. For the year ended March 31, 2025, MCA has not notified any new standards or amendments to the
existing standards appliable to the Company.

Note: The list of undertakings covered under MSMED Act was determined by the Company on the basis of information available with the
Company and has been relied upon by the auditors.

24 Disclosure as per Section 186 of the Companies Act, 2013

The details of loans, guarantees and investments under Section 186 of the Companies Act, 2013 read with the Companies (Meetings ot
Board and its Powers) Rules, 2014 arc as follows :

(i) Details of investments made are given in Note 5(a)

(ii) Loans given by the Company is Nil (as at March 31, 2024: Nil)

(iii) Guarantees given by the Company is Nil (as at March 31,2024: Nil)

25 Segment reporting

A. Basis for segmentation

An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur
expenses, including revenues and expenses that relate to transactions with any of the Company’s other components, and for which discrete
financial information is available. All operating segment''s results arc reviewed regularly by the Company’s Chairman and MD to make
decisions about resources to be allocated to the segments and assess their performance.

The Chief Operating Decision Maker ("CODM") evaluates the Company’s performance and allocates resources based on an analysis of
various performance indicators at operational unit level and since there is single operating segment, no segment disclosures of the company
is presented. The Company’s operations fall within a single business segment “Diagnostic services”.

B. Geographical information

The Company operates within India and therefore there are no assets or liabilities outside India.

C. Major customers

Revenue from any single customer of the Company''s operating segment docs not exceed 10% of the total revenue reported and hence the
there are no major customers to be disclosed.

26 Employee benefit plans

The Company has following post employment benefit plans:

(a) Defined contribution plans

Contributions were made to provident fund (at the rate of 12% of basic salary) and Employee State Insurance in India for the employees of the
Company as per the regulations. These contributions are made to registered funds administered by the Government of India. The obligation of the
Company is limited to the amount contributed and it has no further contractual nor any other constructive obligation. The expense recognised
during the year in the standalone statement of profit and loss towards defined contribution plan is Rs. 11.81 lakhs (March 31, 2024: Rs. 12.06
lakhs).

(b) Defined benefit plan

The Company provides for Gratuity for employees in India as per the Payment of Gratuity Act, 1972. Employees who are in continuous service for
a period of 5 years are eligible for Gratuity. The amount of Gratuity payable on retirement/ termination is the employee''s last drawn basic salary
per month computed proportionately for 15 days salary multiplied for the number of years of service or part thereof in excess ot six months,
restricted to a sum of Rs. 20.00 lakhs. The gratuity plan is an unfunded plan.

This defined benefit plans expose the Company to actuarial risks, such as longevity risk, interest rate risk and market (investment) risk,
i. Reconciliation of the net defined benefit (asset)/ liability

The amounts recognised in the balance sheet and the movements in the defined benefit obligation and fair value of plan assets over the year are as
follows:

The amounts recognised in the balance sheet and the movements in the defined benefit obligation as per the valuation report as at March
31,2025 are produced in the tables below

Tfce Company’s policy is to maintain a stable and strong capital structure with a focus on equity so as to provide returns to shareholders, benefits to other stakeholders, creditors
and to sustain future development and growth of the business. In order to maintain the capital structure, the Company monitors the return on capital as well as debt to total
equity ratio. The Company aims to manage its capital efficiently so as to safeguard its ability to continue as a going concern and to optimise returns to all its shareholders. For
die purpose of debt to total equity, debt includes its long-term and short-term borrowings. Total equity comprises of issued share capital and all other equity reserves. Since the
coial equity is negative, Gearing ratio is not given.

i. Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company''s receivables from
customers and loans.

The Company has no significant concentration of credit risk with any counterparty.

Trade receivables and loans:

Customer credit risk is managed by the respective department subject to Company''s established policy, procedures and control relating to customer credit risk management. Credit quality of a customer is assessed
based on individual credit limits as defined by the Company. Outstanding customer receivables are regularly monitored.

Expected credit loss (ECL) assessment for individual customers:

As per simplified approach, the Company makes provision of expected credit losses on trade receivable using a provision matrix to mitigate the risk of default payment and make appropriate provision at each
reporting date.

The ageing analysis of the receivables has been considered from the date the invoice falls due.

29 Financial instruments (continued)

ii. Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s
approach to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities when they arc due, under both normal and stressed conditions, without incurring unacceptable
losses or risking damage to the Company’s reputation.

The finance team monitors rolling forecasts of the Company''s liquidity position and cash and cash equivalents on the basis of expected cash outflow''s on trade payables and other financial liabilities and any excess/
short liquidity is managed in the form of current borrowings and bank deposits as per the approved frame work.

Exposure to liability risk

The following are the remaining contractual maturities of financial liabilities at the reporting date. The amounts are gross and undiscounted, and include estimated interest payments and exclude the impact of
netting agreements.

31 Code on Social Security, 2020:

The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has
released draft rules for the Code on Social Security, 2020 on November 13,2020, and has invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the
impact and its evaluation once the subject rules are notified and wall give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the
financial impact are published.

33 Other statutory information

i. The Company does not have any Benami property, where any proceeding has been initiated or pending against the Company for holding any Benami
property.

ii. The Company does not have any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act,
1956 during the financial year.

iii. The Company has not traded or invested in Crypto Currency or Virtual Currency during the financial year.

iv. The Company does not have any charges or satisfaction which is yet to be registered with Registrar of Companies (ROC) beyond the statutory period.

v. The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the
understanding that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate
Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries

vi. The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether
recorded in writing or otherwise) that the Company shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate
Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries

vii. The Company has not entered into any transaction which is not recorded in the books of accounts that has been surrendered or disclosed as income
during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act,
1961).

viii. The Company has not been declared as wilful defaulter by any bank or financial institution or other lender.

34 Scheme of Amalgamation .

The Board of Directors of the Company at their meeting held on 26 June 2024, have considered and approved the proposed Scheme of Amalgamation
(''Scheme") of the company ("Transferor Company") with and into the Holding Company, "Vijaya Diagnostic Centre Limited (Transfeiee Company)
with effect from 01 April 2024 (‘the Appointed Date”) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, and other
rules and regulations framed thereunder ("Scheme"). The Company has received letter with “no adverse observations” from the BSE Limited and SEBI
on December 05, 2024, and fiirther vide National Company Law Tribunal ("NCLT"), Hyderabad, order dated March 5, 2025 ("Order"), the companny has
obtained approval of shareholders vide resolution passed at their meeting held on April 25,2025, and pursuant to the said order the NCLT has also
dispensed the meeting of Unsecured Creditors and Unsecured Loan Creditor as they have conveyed their consent in writing for the Scheme of
Amalgamation. The Scheme is subject to the approval of the NCLT, and such other approvals, permissions, and sanctions of regulatory and other
authorities as may be necessary.

For M. Anandam & Co. For and on behalf of the Board of Directors of / I

Chartered Accountants Medinova Diagnostic Services Limited < '' J

ICAI Finn registration number: 000125S CIN:L85110TG1993PLC01 ^481 y

J Cr/l M. V. Abhiram ......^trSnrii Snrendranath Rj ddv Sui/npiandra KondapalW/

/ Partner jX/-'' Chairman '' Mailing Director

^ Membership Number: 266427 DIN: 00108599 DIN Number 01409«2

^j ^ Place: Hyderabad

Date: 03 May, 2025 Chief*Fmancial Officer Company Secretary

Place: Hyderabad
Date: 03 May, 2025

---

Mar 31, 2024

M. Provision, contingent liabilities and contingent assets

A provision is recognised if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably, and it
is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future
cash flows (representing the best estimate of the expenditure required to settle the present obligation at the balance sheet date) at a pre-tax rate that
reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognised under
finance costs. Expected future operating losses are not provided for.

Contingencies:

Provision in respect of loss contingencies relating to claims, litigations, assessments, fines and penalties are recognised when it is probable that a
liability has been incurred and the amount can be estimated reliably.

M. Provision, contingent liabilities and contingent assets (Continued)

Contingent labilities and contingent assets:

A contingent liability exists when there is a possible but not probable obligation, or a present obligation that may, but probably will not, require an
outflow of resources, or a present obligation whose amount cannot be estimated reliably. Contingent liabilities do not warrant provisions, but are
disclosed unless the possibility of outflow of resources is remote.

Contingent assets has to be recognised in the financial statements in the period in which if it is virtually certain that an inflow of economic benefits will
arise. Contingent assets are assessed continually and no such benefits were found for the current financial year.

N. Earnings per share

Basic Earnings Per Share (‘EPS’) is computed by dividing the net profit attributable to the equity shareholders by the weighted average number of
equity shares outstanding during the year. Diluted earnings per share is computed by dividing the net profit by the weighted average number of equity
shares considered for deriving basic earnings per share and also the weighted average number of equity shares that could have been issued upon
conversion of all dilutive potential equity shares. Dilutive potential equity shares are deemed converted as of the beginning of the year, unless issued at
a later date. In computing diluted earnings per share, only potential equity shares that are dilutive and that either reduces earnings per share or increases
loss per share are included. The number of shares and potentially dilutive equity shares are adjusted retrospectively for all periods presented for the
share splits.

O. Statement of Cash Flow

Cash flows are reported using the indirect method, whereby net profit/ (loss) before tax is adjusted for the effects of transactions of a non-cash nature
and any deferrals or accruals of past or future cash receipts or payments and item of income or expenses associated with investing or financing cash
flows. The cash flows from regular revenue generating (operating activities), investing and financing activities of the Company are segregated.

P. Cash and cash equivalents

For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with financial
institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of
cash and which are subject to an insignificant risk of changes in value.

Q. Investments in subsidiaries

Investments representing equity interest in subsidiaries carried at cost less any provision for impairment. Investments are reviewed for impairment if
events or changes in circumstances indicate that the carrying amount may not be recoverable.

R. Events after reporting date

Where events occurring after the balance sheet date provide evidence of conditions that existed at the end of the reporting period, the impact of such
events is adjusted within the financial statements. Otherwise, events after the balance sheet date of material size or nature are only disclosed.

S. Recent accounting pronouncements

Ministry of Corporate Affairs (“MCA”) notifies new standards or amendments to the existing standards under Companies (Indian Accounting
Standards) Rules as issued from time to time. For the year ended March 31, 2024, MCA has not notified any new standards or amendments to the
existing standards appliable to the Company.

24 Disclosure as per Section 186 of the Companies Act, 2013

The details of loans, guarantees and investments under Section 186 of the Companies Act, 2013 read with the Companies (Meetings of
Board and its Powers) Rules, 2014 are as follows :

(i) Details of investments made are given in Note 5(a)

(ii) Loans given by the Company is Nil (as at March 31, 2023: Nil)

(iii) Guarantees given by the Company is Nil (as at March 31, 2023: Nil)

25 Segment reporting

A. Basis for segmentation

An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur
expenses, including revenues and expenses that relate to transactions with any of the Company’s other components, and for which discrete
financial information is available. All operating segment''s results are reviewed regularly by the Company’s Chairman and MD to make
decisions about resources to be allocated to the segments and assess their performance.

The Chief Operating Decision Maker ("CODM") evaluates the Company’s performance and allocates resources based on an analysis of
various performance indicators at operational unit level and since there is single operating segment, no segment disclosures of the company
is presented. The Company’s operations fall within a single business segment “Diagnostic services”.

B. Geographical information

The Company operates within India and therefore there are no assets or liabilities outside India.

C. Major customers

Revenue from any single customer of the Company''s operating segment does not exceed 10% of the total revenue reported and hence the
there are no major customers to be disclosed.

26 Employee benefit plans

The Company has following post employment benefit plans:

(a) Defined contribution plans

Contributions were made to provident fund (at the rate of 12% of basic salary) and Employee State Insurance in India for the employees of the
Company as per the regulations. These contributions are made to registered funds administered by the Government of India. The obligation of the
Company is limited to the amount contributed and it has no further contractual nor any other constructive obligation. The expense recognised
during the year in the standalone statement of profit and loss towards defined contribution plan is Rs. 12.06 lakhs (March 31, 2023: Rs. 12.44
lakhs).

(b) Defined benefit plan

The Company provides for Gratuity for employees in India as per the Payment of Gratuity Act, 1972. Employees who are in continuous service for
a period of 5 years are eligible for Gratuity. The amount of Gratuity payable on retirement/ termination is the employee''s last drawn basic salary
per month computed proportionately for 15 days salary multiplied for the number of years of service or part thereof in excess of six months,
restricted to a sum of Rs. 20.00 lakhs. The gratuity plan is an unfunded plan.

This defined benefit plans expose the Company to actuarial risks, such as longevity risk, interest rate risk and market (investment) risk.
i. Reconciliation of the net defined benefit (asset)/ liability

The amounts recognised in the balance sheet and the movements in the defined benefit obligation and fair value ofplan assets over the year are as
follows:

The amounts recognised in the balance sheet and the movements in the defined benefit obligation as per the valuation report as at March
31, 2024 are produced in the tables below

The Company’s policy is to maintain a stable and strong capital structure with a focus on equity so as to provide returns to shareholders, benefits to other stakeholders, creditors
and to sustain future development and growth of the business. In order to maintain the capital structure, the Company monitors the return on capital as well as debt to total
equity ratio. The Company aims to manage its capital efficiently so as to safeguard its ability to continue as a going concern and to optimise returns to all its shareholders. For
the purpose of debt to total equity, debt includes its long-term and short-term borrowings. Total equity comprises of issued share capital and all other equity reserves. Since the
total equity is negative, Gearing ratio is not given.

34 Other statutory information

i. The Company does not have any Benami property, where any proceeding has been initiated or pending against the Company for holding any Benami
property.

ii. The Company does not have any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act,
1956 during the financial year.

iii. The Company has not traded or invested in Crypto Currency or Virtual Currency during the financial year.

iv. The Company does not have any charges or satisfaction which is yet to be registered with Registrar of Companies (ROC) beyond the statutory period.

v. The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the
understanding that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate
Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries

vi. The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether
recorded in writing or otherwise) that the Company shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate
Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries

vii. The Company has not entered into any transaction which is not recorded in the books of accounts that has been surrendered or disclosed as income during
the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).

viii. The Company has not been declared as wilful defaulter by any bank or financial institution or other lender.

For M. Anandam & Co. For and on behalf of the Board of Directors of

Chartered Accountants Medinova Diagnostic Services Limited

ICAI Firm registration number: 000125S CIN:L85110TG1993PLC015481

Madhuri Chimalgi Dr. Sura Surendranath Reddy Sunil Chandra Kondapally

Partner Chairman Managing Director

Membership Number: 235955 DIN: 00108599 DIN Number: 01409332

Place: Hyderabad Nikhil Rajmal Jain Hansraj Singh Rajput

Date: 26 Apr, 2024 Chief Financial Officer Company Secretary

Place: Hyderabad
Date: 26 Apr, 2024

---

Mar 31, 2016

1. The Company’s operations predominantly related to providing Diagnostic Services and related business services. During the year ended March 31, 2016, there are no other reportable business segments as per AS 17 “Segment reporting".

2. Contingent Liabilities not provided for in the matter of Disputed demand for Provident Fund Rs. 5,61,368 under The Employees Provident Funds and Miscellaneous Provisions Act, 1952 relating for the period 1998-2001, which representation has been submitted before Employees Provident Fund Appellate Tribunal, New Delhi for their consideration and is currently pending for disposal.

3. RELATED PARTY DISCLOSURE

As per Accounting Standard 18, “Related Party Disclosure” issued by the Institute of Chartered Accountants of India, the disclosures of transactions with the related parties as defined in Accounting Standard are given below:

4. Details of related party where control exists and other related party with whom the Company had transactions and their relationships during the financial year.

5. Disclosure required by the AS-15 (Revised) - Employee Benefits.

The Company adopted the revised Accounting Standard - 15 Employee Benefits. The details of components of net benefit expenses recognized in the Profit & Loss Account with regard to gratuity and amounts recognized in the Balance Sheet are below:

6. Previous period’s figures have been re-grouped / rearranged wherever necessary to confirm with current year classification and to facilitate meaningful comparison. Figures are rounded off to nearest rupee.

---

Mar 31, 2015

1. During the year under review the Company has changed the rate of depreciating its assets on Straight Line Basis as per rates prescribed under Companies Act, 1956, to rates based on the expected life time of the assets and their estimated residual value at the end of the life. The depreciation has been recalculated from the date of asset put to use and the incremental depreciation amounting to Rs 2.45 Crores is treated as impairment loss and depreciation for the Current financial year is provided at the new rates of depreciation after considering the effect of impairment as on the first day of financial year.

2. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

3. As per Accounting Standard 18, "Related Party Disclosure" issued by the Institute of Chartered Accountants of India, the disclosures of transactions with the related parties as defined in Accounting Standard are given below:

4. Disclosure required by the AS-15 (Revised) - Employee Benefits.

The Company adopted the revised Accounting Standard – 15 Employee Benefits. The details of components of net benefit expenses recognized in the Profit & Loss Account with regard to gratuity and amounts recognized in the Balance Sheet are below:

5. Previous period's figures have been re-grouped / rearranged wherever necessary to confirm with current year classification and to facilitate meaningful comparison. Figures are rounded off to nearest rupee.

---

Mar 31, 2014

1. Contingent Liabilities not provided for : As at As at 31.03.2014 31.03.2013 (Rupees) (Rupees)

Provident Fund interest demand 5,61,368 5,61,368

2. Balances of Secured Loans, Sundry Debtors and Sundry Creditors, Loans and Advances payable or receivable are subject to confirmations to be obtained from the parties.

3. Exceptional Items

4. During the year, Based on the proposal received from M/s. Mallya Hospital (Managed by Chaparral Health Services Limited), a unit of the company situated at No. 55, Infantry Road, Shivaji Nagar, Bangalore-560001, has been sold and transferred to M/s. Mallya Hospital (Purchaser), as-a-going-concern, on slump sale basis, together with all its assets and liabilities on as is where is basis but excluding the use of Medinova Brand Name with effect from 31.01.2014 (the appointed date) for a total consideration of Rs.715.00 lakhs.

5. The company in its Board Meeting dated 18.03.2014 has approved the sale of Bangalore unit.

6. The said sale consideration was adjusted against the amounts due to the said company.

7. The employees of the transferred undertaking were transferred to the Purchaser on their existing terms of employment with the company.

8. The contingent Liabilities of the transferred undertaking were also transferred to the Purchaser as on the appointed date.

9. Post transfer of the transferred undertaking, the company''s retained business includes the diagnostic service centres at Hyderabad, Pune, Kolkata and a mini centre at Bansdroni (Kolkata).

10. Related Party Transactions :

As required by Accounting Standard - AS 18 "Related Party Disclosures" issued by The Institute of Chartered Ac- countants of India, details of transactions of related parties with whom transactions have taken place during the year are as follows:

11. During the year, the company had entered into a Tripartite "Deed of Assignment of Debt" with M/s. Standard Medical Pharmaceuticals Limited (SMPL) and M/s. Harvins Constructions Private Limited (HCPL) for assignment of Debts receivable / payable as on 31.01.2014 and accordingly assigned the Debts receivable from M/s. SMPL with that of the Debts payable to M/s. HCPL, for an aggregate amount of Rs. 12,35,38,622/-

12. Upon execution of the said ''Deed of Assignment of Debt'', the Call Deposit, Advances and Accrued Interest out- standing from the Related Party M/s. SMPL stands settled as on 31.01.2014.

13. During the year M/s. Vijaya Diagnostic Centre Private Limited had entered into an Agreement for acquiring 27,50,220 equity shares equivalent to 29.01% (29.16% of Voting Capital of MDSL) shareholding from the promoter company M/s. Standard Medical & Pharmaceuticals Limited and has made open offer for additional 26% of the Equity Shares as mandated under Regulation 3(1) & 4 of the SEBI (SAST) Regulations, 2011. Consequently, M/s. Vijaya Diagnostic Centre Private Limited after completion of the open offer and acquisition of shares from the promoter company would acquire the management control and become the promoter of the company.

14. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

15. There are no dues to Micro, Small & Medium Enterprises (MSME) as at the Balance Sheet date and no interest has been paid to any such parties. This is based on the information on such parties having been identified on the basis of information available with the Company and relied upon by the Auditors. Hence Trade Payables in Note No. 9 represent payable to creditors other than MSME.

16. Previous year''s figures have been regrouped / reclassified wherever necessary to correspond with the Current year''s classification / disclosure.

---

Mar 31, 2013

1. Contingent Liabilities not provided for :

As at 31.03.2013 As at 31.03.2012 (Rupees) (Rupees)

Provident Fund interest demand 5,61,368 5,61,368

2. Managerial Remuneration:` 2012-2013 2011-2012 (Rupees) (Rupees)

Sri. N. Ravi Kumar, Manager (Designated as Chief Operating Officer) 2,88,000 2,82,700

3. Balances of Secured Loans, Sundry Debtors and Sundry Creditors, Loans and Advances payable or receivable are subject to confirmations to be obtained from the parties.

a) Disclosure regarding Loans & Advances in the nature of Loans to subsidiaries, associates, etc., and their investments in shares of the Company, as required under clause 32 of Listing Agreement.

4. As detailed in Note No.29, dues from M/s. Standard Medical & Pharmaceuticals Limited represents advances in connection with spin-off and subsequent transactions. In view of the settlement arrangement reached with the said Company, no further interest is to be charged on the dues w.e.f. 1st April, 2004 and the said dues are to be repaid by the said Company in a phased manner. The company is confident of recovery of the same and hence no provision has been made in the accounts.

5. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

6. There are no dues to Micro, Small & Medium Enterprises (MSME) as at the Balance Sheet date and no interest has been paid to any such parties. This is based on the information on such parties having been identified on the basis of information available with the Company and relied upon by the Auditors. Hence Trade Payables in Note No. 8 represent payable to creditors other than MSME.

7. Previous year''s figures have been regrouped / reclassified wherever necessary to correspond with the Current year''s classification / disclosure.

---

Mar 31, 2012

1. Balances of Secured Loans, Sundry Debtors and Sundry Creditors, Loans and Advances payable or receivable are subject to confirmations to be obtained from the parties.

2. Related Party Transactions :

As required by Accounting Standard - AS 18 “Related Pfcrty Disclosures issued by The Institute of Chartered Accountants of India, details of transactions of related parties with whom transactions have taken place during the year are as follows:

3. As detailed in Note No.29, dues from M/s. Standard Medical & Pharmaceuticals Limited represents advances in connection with spin-off and subsequent transactions. In view of the settlement arrangement reached with the said Company, no further interest is to be charged on the dues w.e.f. 1st April, 2004 and the said dues are to be repaid by the said Company in a phased manner. The company is confident of recovery of the same and hence no provision has been made in the accounts.

4. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

5. Disclosure required by the AS-15 (Revised) - Employee Benefits.

The Company adopted the revised Accounting Standard -15 Employee Benefits. The details of the componentstoif nefl&tiefit expenses recognised in the profit and loss account with regard to gratuity and amounts recognised in the Balance Sheet are given below.

6. There are no dues to Micro, Small & Medium Enterprises (MSME) as at the Balance Sheet date and no Interest has been paid to any such parties. This is based on the information on such parties having been identified on the basis of Information available with the Company and relied upon by the Auditors. Hence Trade Payables In Note No. 8 represent payable to creditors other than MSME.

---

Mar 31, 2011

1. Secured Loan: Working capital loan from a Scheduled Bank is secured by hypothecation of stocks, book debts and machinery. The said loan is further guaranteed by personal guarantee of a director of the company.

2. Contingent Liabilities not provided for :

As at 31.03.2011 As at 31.03.2010 (Rupees) (Rupees)

Provident Fund interest demand 5,61,368 7,46,889

3. Balances of Secured Loans, Sundry Debtors and Sundry Creditors, Loans and Advances payable or receivable are subject to confirmations to be obtained from the parties.

4. Prior period adjustments represents interest on Income Tax Rs.24,640/- (previous year Rs.48,870).

5. There were no dues to SSI units as at the year end.

6. As detailed in Note No.8, dues from M/s. Standard Medical & Pharmaceuticals Limited represents advances in connection with spin-off and subsequent transactions. In view of the settlement arrangement reached with the said Company, no further interest is to be charged on the dues w.e.f. 1st April, 2004 and the said dues are to be repaid by the said Company in a phased manner. The company is confident of recovery of the same and hence no provision has been made in the accounts.

7. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

8. Computation of Earning per share is not applicable since the net results is loss.

9. Previous year's figures have been re-grouped wherever necessary to confirm the figures for the current year.

---

Mar 31, 2010

1. Liabilities relating to foreign currency buyers credit have been guaranteed by Nationalised Banks which in turn are secured by way of hypothecation of Machinery of the Hyderabad Diagnostic Centre and further guaranteed by personal guarantee of one of the Directors.

2. Contingent Liabilities not provided for :

As at 31.03.2010 As at 31.03.2009

(Rupees) (Rupees)

Provident Fund interest demand 7,46,889 7,46,889

3. Balances of Secured Loans, Sundry Debtors and Sundry Creditors, Loans and Advances payable or receivable are subject to confirmations to be obtained from the parties.

4. There were no dues to SSI units as at the year end.

5. As detailed in Note No.8, dues from M/s. Standard Medical & Pharmaceuticals Limited represents advances in connection with spin-off and subsequent transactions. In view of the settlement arrangement reached with the said Company, no further interest is to be charged on the dues w.e.f. 1st April, 2004 and the said dues are to be repaid by the said Company in a phased manner. The company is confident of recovery of the same and hence no provision has been made in the accounts.

6. The Company is engaged in the business of Diagnostic Services and related business. There are no other reportable business segments.

7. Computation of Earning per share is not applicable since the net results is loss.

8. Previous years figures have been re-grouped wherever necessary to confirm the figures for the current year.

9. Information as required under Part -IV, schedule VI of the Companies Act, 1956 is given hereunder.